- Home
- AXSM vs RITM Comparison
AXSM vs RITM Comparison
Compare AXSM & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- RITM
- Stock Information
- Founded
- AXSM 2012
- RITM 2011
- Country
- AXSM United States
- RITM United States
- Employees
- AXSM N/A
- RITM 6045
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- RITM Real Estate Investment Trusts
- Sector
- AXSM Health Care
- RITM Real Estate
- Exchange
- AXSM Nasdaq
- RITM Nasdaq
- Market Cap
- AXSM 5.1B
- RITM 6.0B
- IPO Year
- AXSM 2015
- RITM N/A
- Fundamental
- Price
- AXSM $105.16
- RITM $11.15
- Analyst Decision
- AXSM Strong Buy
- RITM Strong Buy
- Analyst Count
- AXSM 15
- RITM 8
- Target Price
- AXSM $170.20
- RITM $13.13
- AVG Volume (30 Days)
- AXSM 612.2K
- RITM 4.3M
- Earning Date
- AXSM 05-05-2025
- RITM 04-25-2025
- Dividend Yield
- AXSM N/A
- RITM 8.97%
- EPS Growth
- AXSM N/A
- RITM N/A
- EPS
- AXSM N/A
- RITM 1.19
- Revenue
- AXSM $432,157,000.00
- RITM $3,560,550,000.00
- Revenue This Year
- AXSM $63.30
- RITM N/A
- Revenue Next Year
- AXSM $61.15
- RITM $2.35
- P/E Ratio
- AXSM N/A
- RITM $9.35
- Revenue Growth
- AXSM 72.16
- RITM 10.49
- 52 Week Low
- AXSM $64.11
- RITM $9.13
- 52 Week High
- AXSM $139.13
- RITM $12.20
- Technical
- Relative Strength Index (RSI)
- AXSM 45.61
- RITM 48.45
- Support Level
- AXSM $101.41
- RITM $10.96
- Resistance Level
- AXSM $106.77
- RITM $11.37
- Average True Range (ATR)
- AXSM 3.18
- RITM 0.18
- MACD
- AXSM -0.23
- RITM -0.05
- Stochastic Oscillator
- AXSM 39.33
- RITM 24.67
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.